ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,815.26
-0.76%
US Tech 100
19,622.00
-1.40%
Dow Jones
42,740.42
-0.75%
Brent Oil
74.47
-0.59%
Bitcoin
66,865.19
1.22%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Repligen Corp (RGEN) Quote

Repligen Corp

Repligen Corp (RGEN)

NASDAQ
144.98
1.93
(1.35%)
At close: October 15 4:00PM
Delayed by 15 minutes
144.98
-0.04
( -0.03% )
After Hours: 5:30PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
144.98
Bid
125.00
Ask
150.36
Volume
573,463
143.22 Day's Range 147.35
110.45 52 Week Range 211.13
Market Cap
8.12B
Previous Close
143.05
Open
143.22
Last Trade
10077
@
144.98
(average)
Last Trade Time
17:23:17
Financial Volume
$ 83,652,235
VWAP
145.8721
Average Volume (3m)
808,818
Shares Outstanding
56,006,498
Dividend Yield
-
PE Ratio
195.34
Earnings Per Share (EPS)
0.74
Revenue
669.33M
Net Profit
41.58M

About Repligen Corp

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceuti... Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.repligen.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Repligen Corp is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker RGEN. The last closing price for Repligen was $143.05. Over the last year, Repligen shares have traded in a share price range of $ 110.45 to $ 211.13.

Repligen currently has 56,006,498 shares outstanding. The market capitalization of Repligen is $8.01 billion. Repligen has a price to earnings ratio (PE ratio) of 195.34.

Ask ADVFN Intelligence (AI)

Repligen (RGEN) Options Flow Summary

RGEN Options Flow

Overall Flow

Bullish

Net Premium

31k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

RGEN Latest News

More News

Repligen Opens Training & Innovation Center to Elevate Customer Experience

WALTHAM, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening...

September 24 2024
GlobeNewswire Inc.

Form 8-K - Current report

September 18 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

September 12 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

September 10 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

September 04 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

September 04 2024
Edgar (US Regulatory)

Repligen Corporation to Present at Wells Fargo Healthcare Conference

WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be...

August 23 2024
GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

August 19 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

August 05 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

August 02 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
19.386.91740412979135.6145.02133.34446878137.56116085CS
44.233.0053285968140.75150.84133.34570663141.56743822CS
124.723.36517895337140.26172.65127.74808818148.67234066CS
26-28.78-16.5630755064173.76176.94113.5734085145.40456521CS
52-6.58-4.34151491159151.56211.13110.45672606156.57017182CS
156-129.801-47.2379822477274.781306.98110.45576252173.39832012CS
26066.4484.59383753578.54327.3276.745522102167.72936938CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STECSantech Holdings Limited
$ 3.49
(807.44%)
9.72M
CTCXCarmell Corporation
$ 0.73
(111.17%)
11.72M
VSVersus Systems Inc
$ 1.77
(53.91%)
1.91M
TPSTTempest Therpeutics Inc
$ 1.61
(37.61%)
4.85M
BDRXBiodexa Pharmaceuticals PLC
$ 6.45
(28.74%)
576.42k
PENGPengiun Solutions Inc
 16.5503
(-18.91%)
88.66k
DRCTDirect Digital Holdings Inc
$ 3.08
(-14.21%)
12.55k
JDZGJIADE Ltd
$ 0.9589
(-13.61%)
402.49k
ALRNAileron Therapeutics Inc
$ 3.21
(-13.01%)
256
TCJHTop KingWin Ltd
$ 0.44
(-11.82%)
1.98k
CTCXCarmell Corporation
$ 0.73
(111.17%)
11.72M
STECSantech Holdings Limited
$ 3.49
(807.44%)
9.72M
NVDANVIDIA Corporation
$ 131.05
(-0.42%)
6.18M
HAOHaoxi Health Technology Ltd
$ 0.1927
(5.42%)
5.74M
GRTSGritstone bio Inc
$ 0.0675
(-1.60%)
5.61M

RGEN Discussion

View Posts
Monksdream Monksdream 1 month ago
RGEN under $200
šŸ‘ļø0
Monksdream Monksdream 3 months ago
RGEN under $200
šŸ‘ļø0
Monksdream Monksdream 6 months ago
RGEN over $30
šŸ‘ļø0
Monksdream Monksdream 8 months ago
RGEN new 52 week high
šŸ‘ļø0
Dennisb68 Dennisb68 9 months ago
Hoping it holds.
šŸ‘ļø0
Monksdream Monksdream 9 months ago
RGEN new 52 week high
šŸ‘ļø0
Dennisb68 Dennisb68 10 months ago
Another very good day for RGEN. Up 6.8%
šŸ‘ļø0
Dennisb68 Dennisb68 1 year ago
Good day for RGEN. Hope we see more of them.
šŸ‘ļø0
Dennisb68 Dennisb68 2 years ago
Do these execs ever BUY the stock?
šŸ‘ļø0
Dennisb68 Dennisb68 2 years ago
It had great earning last quarter.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Good day. Over $300 at one point.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
She continues to make new highs almost daily.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Another new closing high. It just gets better and better.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
New high, $300.00 in AH trading.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Still making new highs almost daily.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
It continues to make new highs...
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Today was the biggest gain ever for RGEN.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
WOW, What a quarter!
https://finance.yahoo.com/news/repligen-reports-second-quarter-2021-113000794.html
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Lost a little ground today. Back below $205.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Still holding above $205 and after the recent run I'm happy with that.
šŸ‘ļø0
Dennisb68 Dennisb68 3 years ago
Good to see the stock above $205 again.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
HC Wainwright & Co. boosted the price target for Repligen Corporation
RGEN 0.53%
from $168 to $225.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
RGEN hit a new all time high today.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Actually it a little more than doubled in 2020. It closed 2019 at 92.50 and it closed 2020 at 191.63 for a 107% gain. If it doubles again in 2021 I will be paying a LOT of taxes.
šŸ‘ļø0
Jamins Jamins 4 years ago
222.06 today. Doubled in value in 2020 and company says it will do it again in 2021. So what do you got to lose?
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
RGEN having a great day but not seeing any news to justify it. Perhaps news of an acquisition is coming?
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
I sold half my shares at $159 and was able to get back in at $143. If we get a nice run higher I my sell again and wait for a dip to get back in. Just watching it day by day.
šŸ‘ļø0
keepemcloser keepemcloser 4 years ago
Same here,we feel comfortable at this level.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Great earnings and the stock closes at another all time high.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Stock closed at another all time closing high.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Moved higher in AH trading.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
The stock continues to make new highs. $170 and headed for $200.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
RGEN hit a new 52 week high today.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Thank you. Yes a very nice profit as I bought these at about $3.50 a share. I'm still holding quite a few shares.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
Nice profit! I am new here and long!
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Sold half my position this morning. Like the stock but feel the markets are due for a dip.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Up another $2 in AH trading. Hope it holds. I think we could see $165 in the near future. What I would love to see the company do is a stock split about 1 for 5 or 1 for 8. I have talked to the company and they have said they have given it some thought but nothing yet.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
Holding for the big move
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Are you still holding your share after today's run?
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Earnings:

https://www.otcmarkets.com/filing/html?id=14296416&guid=d5eFUHutqUUibth
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Earning out and they are GREAT..

šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Another very nice day. Currently trading over $140,00
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
$139.00 in Pre Mkt. this morning.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
The majority of the stocks I trade are OTC stocks.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
TDA and E*TRADE charge no fees on non otcs
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
Really? Check your statement to see if you aren't paying any fees.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
BTW no brokers charge commission fees anymore.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
Yes of course. Iā€™m not wealthy and am 37. Just began investing in this after lengthy due diligence led me here.
šŸ‘ļø0
Dennisb68 Dennisb68 4 years ago
When I buy stocks I pay a $7 commission if I buy 1 share or 100 shares. If I bought 1 share for $130 it would cost me $137 with commission. And then when I sold it I would have to pay another $7 in commission so I would have to sell that stock I bought for $130 for $144 just to break even.
šŸ‘ļø0
Hitman970 Hitman970 4 years ago
Yes sir I do.
šŸ‘ļø0

Your Recent History

NASDAQ
RGEN
Repligen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved